I thought Pharmacy model via Cipla was in conjunction of via Respiri direct using Openpay model, so no issue for mine? Sales direct will be low, the focus is on an overall healthcare approach in conjunction with your pharmacist will see 95% or more of the pull through IMHO.
- Forums
- ASX - By Stock
- RSH
- Media Reports
Media Reports, page-22
-
- There are more pages in this discussion • 297 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RSH (ASX) to my watchlist
|
|||||
Last
2.9¢ |
Change
0.002(7.41%) |
Mkt cap ! $37.25M |
Open | High | Low | Value | Volume |
2.8¢ | 2.9¢ | 2.8¢ | $2.287K | 80K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 47271 | 2.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.9¢ | 109691 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 47271 | 0.027 |
2 | 750000 | 0.026 |
5 | 901055 | 0.025 |
3 | 128161 | 0.023 |
1 | 3245 | 0.021 |
Price($) | Vol. | No. |
---|---|---|
0.029 | 109691 | 3 |
0.030 | 372561 | 4 |
0.033 | 18333 | 1 |
0.034 | 400000 | 1 |
0.035 | 289456 | 3 |
Last trade - 12.55pm 27/08/2024 (20 minute delay) ? |
Featured News
RSH (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online